Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics …
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular
Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and …
Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and …
Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs
L Kumari, Y Choudhari, P Patel, GD Gupta, D Singh… - Life, 2023 - mdpi.com
A drug's aqueous solubility is defined as the ability to dissolve in a particular solvent, and it
is currently a major hurdle in bringing new drug molecules to the market. According to some …
is currently a major hurdle in bringing new drug molecules to the market. According to some …
Drug delivery strategies for poorly water-soluble drugs
A Fahr, X Liu - Expert opinion on drug delivery, 2007 - Taylor & Francis
The drug candidates coming from combinatorial chemistry research and/or the drugs
selected from biologically based high-throughput screening are quite often very lipophilic, as …
selected from biologically based high-throughput screening are quite often very lipophilic, as …
Impact of dendrimers on solubility of hydrophobic drug molecules
Adequate aqueous solubility has been one of the desired properties while selecting drug
molecules and other bio-actives for product development. Often solubility of a drug …
molecules and other bio-actives for product development. Often solubility of a drug …
Dendrimers as drug carriers: applications in different routes of drug administration
Y Cheng, Z Xu, M Ma, T Xu - Journal of pharmaceutical sciences, 2008 - Elsevier
Dendrimers have successfully proved themselves as useful additives in different routes of
drug administration because they can render drugs greater water‐solubility, bioavailability …
drug administration because they can render drugs greater water‐solubility, bioavailability …
Dendrimers: novel polymeric nanoarchitectures for solubility enhancement
U Gupta, HB Agashe, A Asthana, NK Jain - Biomacromolecules, 2006 - ACS Publications
Poor solubility and hydrophobicity of drugs/bioactives limit their possible applications in drug
delivery and formulation development. Apart from conventional methods of solubility …
delivery and formulation development. Apart from conventional methods of solubility …
Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers
C Yiyun, M Na, X Tongwen, F Rongqiang… - Journal of …, 2007 - Elsevier
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most frequently used drugs in
the world, primarily for symptoms associated with osteoarthritis and other chronic …
the world, primarily for symptoms associated with osteoarthritis and other chronic …
Biomedical nanomaterials for immunological applications: ongoing research and clinical trials
V Lenders, X Koutsoumpou, A Sargsian… - Nanoscale …, 2020 - pubs.rsc.org
Research efforts on nanomaterial-based therapies for the treatment of autoimmune diseases
and cancer have spiked and have made rapid progress over the past years. Nanomedicine …
and cancer have spiked and have made rapid progress over the past years. Nanomedicine …
Bioapplications of poly (amidoamine)(PAMAM) dendrimers in nanomedicine
N Taghavi Pourianazar, P Mutlu, U Gunduz - Journal of Nanoparticle …, 2014 - Springer
Abstract Poly (amidoamine)(PAMAM) dendrimers are a novel class of spherical, well-
designed branching polymers with interior cavities and abundant terminal groups on the …
designed branching polymers with interior cavities and abundant terminal groups on the …
Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study
Quinolones, an expanding class of clinically established potent antibiotics, is not freely
soluble in water which prevents the design of liquid dosage forms and restricts their use in …
soluble in water which prevents the design of liquid dosage forms and restricts their use in …